{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:24:34Z","timestamp":1791498274078,"version":"4.3.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.parkreldis.2015.12.002","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T21:28:51Z","timestamp":1450214931000},"page":"99-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Leukocyte glucocerebrosidase and \u03b2-hexosaminidase activity in sporadic and genetic Parkinson disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Han-Joon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beomseok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junghan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woong-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Won","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2015.12.002_bib1","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/brain\/awu002","article-title":"Glucocerebrosidase is shaking up the synucleinopathies","volume":"137","author":"Siebert","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.12.002_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.parkreldis.2015.12.002_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2015.12.002_bib4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/mds.25772","article-title":"Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease","volume":"29","author":"Parnetti","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.12.002_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/mds.26200","article-title":"Plasma oligomeric alpha-synuclein is associated with glucocerebrosidase activity in Gaucher disease","volume":"30","author":"Nuzhnyi","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.12.002_bib6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/brain\/awt367","article-title":"Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease","volume":"137","author":"Murphy","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.12.002_bib7","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/mds.25972","article-title":"Is elevated beta-hexosaminidase activity a potential biomarker for Parkinson's disease?","volume":"29","author":"McNeill","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.12.002_bib8","series-title":"Biochemical Genetics. A Laboratory Manual","first-page":"1","author":"Shapira","year":"1989"},{"key":"10.1016\/j.parkreldis.2015.12.002_bib9","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/brain\/awv179","article-title":"Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations","volume":"138","author":"Alcalay","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.12.002_bib10","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1096\/fj.04-1917fje","article-title":"\u03b1-synuclein induces apoptosis by altered expression in human peripheral lymphocyte in Parkinson's disease","volume":"18","author":"Kim","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.parkreldis.2015.12.002_bib11","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.neurobiolaging.2008.06.010","article-title":"Lymphomonocyte alpha-synuclein levels in aging and in Parkinson disease","volume":"31","author":"Brighina","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2015.12.002_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/mds.25248","article-title":"The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease","volume":"28","author":"Duran","year":"2013","journal-title":"Mov. Disord."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015300572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015300572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T14:35:32Z","timestamp":1567434932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802015300572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":12,"alternative-id":["S1353802015300572"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.12.002","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukocyte glucocerebrosidase and \u03b2-hexosaminidase activity in sporadic and genetic Parkinson disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}